{"schema_version":"1","generated_at":"2026-11-10T04:31:33.242Z","data_as_of":null,"url":"https://www.findmykol.com/kol/pavlos-msaouel","json_url":"https://www.findmykol.com/kol/pavlos-msaouel/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"pavlos-msaouel","name":"Pavlos Msaouel","credential":"MD, PhD","specialty":"Internal Medicine","specialty_raw":"Internal Medicine","therapeutic_area":"Primary Care","therapeutic_areas":["Primary Care"],"institution":"The University of Texas MD Anderson Cancer Center","institution_url":"https://www.findmykol.com/institution/the-university-of-texas-md-anderson-cancer-center","city":"Houston","state":"TX","region":{"label":"South Central","url":"https://www.findmykol.com/region/south-central"}},"identifiers":{"npi":"1154617983","orcid":"0000-0001-6505-8308","openalex":"A5080220488"},"summary":"Pavlos Msaouel is a Primary Care physician affiliated with The University of Texas MD Anderson Cancer Center. OpenAlex indexes 444 publications with 6,764 citations (h-index 44); ClinicalTrials.gov lists 6 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Internal Medicine profiles in the FindMyKOL directory.","overview":null,"focus":{"indications":[],"research_topics":["Primary Care"]},"scholarship":{"works_count":444,"cited_by_count":6764,"h_index":44,"latest_activity_year":2026,"citation_standing":{"top_percent":10,"cohort":"Internal Medicine","method":"https://www.findmykol.com/about#citation-standing"},"source":"works"},"trials":{"count":6,"shown":3,"withheld":3,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT07438626","title":"Phase II Trial of Sacituzumab Tirumotecan in Patients With SMARCB1-Deficient Renal Medullary Carcinoma","phase":"PHASE2","status":"RECRUITING","role":"Overall official","sponsor":"M.D. Anderson Cancer Center","source_url":"https://clinicaltrials.gov/study/NCT07438626","trial_url":"https://www.findmykol.com/trial/NCT07438626"},{"nct":"NCT06940518","title":"Phase II Trial of Ivonescimab in Previously Treated Patients With Advanced Clear Cell Renal Cell Carcinoma","phase":"PHASE2","status":"RECRUITING","role":"Overall official","sponsor":"M.D. Anderson Cancer Center","source_url":"https://clinicaltrials.gov/study/NCT06940518","trial_url":"https://www.findmykol.com/trial/NCT06940518"},{"nct":"NCT06444880","title":"Phase II Trial of Ubamatamab Alone or in Combination With Cemiplimab in MUC16-Expressing SMARCB1-Deficient Malignancies","phase":"PHASE2","status":"ACTIVE_NOT_RECRUITING","role":"Overall official","sponsor":"M.D. Anderson Cancer Center","source_url":"https://clinicaltrials.gov/study/NCT06444880","trial_url":"https://www.findmykol.com/trial/NCT06444880"}],"source":"trials"},"payments":{"company_count":9,"program_years":{"first":2021,"last":null},"rows_total":23,"shown":3,"withheld":20,"rows":[{"payer":"Mirati Therapeutics","program_year":2025,"amount_usd":899074.96,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1154617983"},{"payer":"Regeneron","program_year":2025,"amount_usd":350000,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1154617983"},{"payer":"Exelixis Inc.","program_year":2025,"amount_usd":396.51,"payment_count":33,"source_url":"https://openpaymentsdata.cms.gov/search?query=1154617983"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1154617983","source":"payments"},"funding":{"award_count":2,"fiscal_years":{"first":2024,"last":2026},"rows_total":6,"shown":3,"withheld":3,"matched_by":"principal investigator name at an organization in the practice state","rows":[{"project":"R37CA288448","title":"Mechanisms of Hyperprogression to Immunotherapy in SMARCB1-Deficient Renal Malignancies","fiscal_year":2026,"amount_usd":"672300","organization":"UNIVERSITY OF TX MD ANDERSON CAN CTR","source_url":"https://reporter.nih.gov/quickSearch/R37CA288448"},{"project":"R01CA285454","title":"Elucidating T Cell Ferroptosis in Renal Medullary Carcinoma: 3D Genome Architecture Rewiring and Therapeutic Alleviation","fiscal_year":2026,"amount_usd":"671046","organization":"UNIVERSITY OF TX MD ANDERSON CAN CTR","source_url":"https://reporter.nih.gov/quickSearch/R01CA285454"},{"project":"R37CA288448","title":"Mechanisms of Hyperprogression to Immunotherapy in SMARCB1-Deficient Renal Malignancies","fiscal_year":2025,"amount_usd":"672300","organization":"UNIVERSITY OF TX MD ANDERSON CAN CTR","source_url":"https://reporter.nih.gov/quickSearch/R37CA288448"}],"source":"grants"},"similar":[{"name":"Hagop Kantarjian","slug":"hagop-kantarjian","institution":"The University of Texas MD Anderson Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/hagop-kantarjian","json_url":"https://www.findmykol.com/kol/hagop-kantarjian/profile.json"},{"name":"Gabriel Hortobagyi","slug":"gabriel-hortobagyi","institution":"The University of Texas MD Anderson Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/gabriel-hortobagyi","json_url":"https://www.findmykol.com/kol/gabriel-hortobagyi/profile.json"},{"name":"Jaffer Ajani","slug":"jaffer-ajani","institution":"The University of Texas MD Anderson Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/jaffer-ajani","json_url":"https://www.findmykol.com/kol/jaffer-ajani/profile.json"},{"name":"Funda Meric-Bernstam","slug":"funda-meric-bernstam","institution":"The University of Texas MD Anderson Cancer Center","specialty":"Surgery","url":"https://www.findmykol.com/kol/funda-meric-bernstam","json_url":"https://www.findmykol.com/kol/funda-meric-bernstam/profile.json"},{"name":"Fei Wang","slug":"fei-wang","institution":"Cornell University","specialty":"Family Medicine","url":"https://www.findmykol.com/kol/fei-wang","json_url":"https://www.findmykol.com/kol/fei-wang/profile.json"},{"name":"Michael Hassman","slug":"michael-hassman","specialty":"Adult Medicine","url":"https://www.findmykol.com/kol/michael-hassman","json_url":"https://www.findmykol.com/kol/michael-hassman/profile.json"},{"name":"Barbara Rizzardi","slug":"barbara-rizzardi","specialty":"Internal Medicine","url":"https://www.findmykol.com/kol/barbara-rizzardi","json_url":"https://www.findmykol.com/kol/barbara-rizzardi/profile.json"},{"name":"Kimball Johnson","slug":"kimball-johnson","specialty":"Internal Medicine","url":"https://www.findmykol.com/kol/kimball-johnson","json_url":"https://www.findmykol.com/kol/kimball-johnson/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":3,"payments":20,"funding":3}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"}},"methodology_url":"https://www.findmykol.com/about#methodology"}